AI assistant
CANN GROUP LIMITED — Share Issue/Capital Change 2020
Jun 14, 2020
64603_rns_2020-06-14_ef83d42a-f2c7-4651-9f92-3538867a7274.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
==> picture [585 x 60] intentionally omitted <==
ASX ANNOUNCEMENT
15 June 2020
NOTICE GIVEN UNDER SECTION 708A(5)(e) OF CORPORATIONS ACT
15 June 2020: Cann Group Limited ( Cann ) (ASX: CAN) gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) ( Corporations Act ) that:
-
(a) Cann has on 15 June 2020 issued 325,272 fully paid ordinary shares by way of a placement to Commonwealth Scientific and Industrial Research Organisation ( CSIRO ), a sophisticated investor, as settlement of an invoice for services rendered without disclosure to the investor under Part 6D.2 of the Corporations Act ; and
-
(b) as at the date of this notice:
-
(1) Cann has complied with the provisions of Chapter 2M of the Corporations Act as they apply to Cann;
-
(2) Cann has complied with section 674 of the Corporations Act ; and
-
(3) there is no information that is “excluded information” within the meaning of sections 708A(7) and 708A(8) of the Corporations Act that is required to be set out in this notice under section 708A(6)(e) of the Corporations Act .
-
Authorised for release by Geraldine Farrell, Company Secretary, Cann Group Limited.
For further information please contact:
Peter Crock Clive Fanning Matthew Wright CEO Head of Investor Relations NWR Communications Cann Group Limited Cann Group Limited +61 451 896 420 +61 3 9095 7088 +61 498 000 762 [email protected] [email protected] [email protected]
About Cann Group
Cann Group Limited (ABN 25 603 949 739) is building a world-class business focused on breeding, cultivating, manufacturing and supplying medicinal cannabis for sale and use within Australia and for approved overseas export markets. The company has established research and cultivation facilities in Melbourne and is developing a state-of-the-art cultivation facility near Mildura, Victoria. Cann Group has executed collaboration agreements that have enabled it to establish a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions. The Company is commercialising a range of imported and locally sourced and manufactured medicinal cannabis products. Learn more about Cann Group at www.canngrouplimited.com
Cann Group Limited ACN 603 949 739 4 Research Avenue, Bundoora, VIC 3083 Australia Ph: +61 3 9095 7088